Detalhe da pesquisa
1.
Th1 cytokines are more effective than Th2 cytokines at licensing anti-tumour functions in CD40-activated human macrophages in vitro.
Eur J Immunol
; 44(1): 162-72, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24114634
2.
A cytokine-neutralizing antibody as a structural mimetic of 2 receptor interactions.
Proc Natl Acad Sci U S A
; 105(51): 20251-6, 2008 Dec 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-19073914
3.
An Antibody Targeting ICOS Increases Intratumoral Cytotoxic to Regulatory T-cell Ratio and Induces Tumor Regression.
Cancer Immunol Res
; 8(12): 1568-1582, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32999002
4.
A therapeutic antibody targeting osteoprotegerin attenuates severe experimental pulmonary arterial hypertension.
Nat Commun
; 10(1): 5183, 2019 11 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31729368
5.
Rational Selection of Syngeneic Preclinical Tumor Models for Immunotherapeutic Drug Discovery.
Cancer Immunol Res
; 5(1): 29-41, 2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27923825
6.
Identification and Characterization of MEDI4736, an Antagonistic Anti-PD-L1 Monoclonal Antibody.
Cancer Immunol Res
; 3(9): 1052-62, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-25943534
7.
Improved drug-like properties of therapeutic proteins by directed evolution.
Protein Eng Des Sel
; 25(10): 631-8, 2012 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-22942395
8.
Combining TGF-beta inhibition and angiotensin II blockade results in enhanced antifibrotic effect.
Kidney Int
; 66(5): 1774-84, 2004 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-15496148